Actinium Pharmaceuticals (ATNM)

Actinium Pharmaceuticals (ATNM) Stock Price & Analysis


ATNM Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$5.87 - $15.12
Previous Close$6.21
Average Volume (3M)163.49K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$91.28M
Total Debt (Recent Filing)$9.15M
Price to Earnings (P/E)-3.5
Mar 15, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.80
Shares Outstanding26,997,587
10 Day Avg. Volume215,626
30 Day Avg. Volume163,487
Standard Deviation0.24
Financial Highlights & Ratios
Price to Book (P/B)3.20
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-3.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Price Target Upside345.45% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Actinium Pharmaceuticals’s price range in the past 12 months?
Actinium Pharmaceuticals lowest stock price was $5.87 and its highest was $15.12 in the past 12 months.
    What is Actinium Pharmaceuticals’s market cap?
    Currently, no data Available
    When is Actinium Pharmaceuticals’s upcoming earnings report date?
    Actinium Pharmaceuticals’s upcoming earnings report date is Mar 15, 2024 which is in 171 days.
      How were Actinium Pharmaceuticals’s earnings last quarter?
      Currently, no data Available
      Is Actinium Pharmaceuticals overvalued?
      According to Wall Street analysts Actinium Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does Actinium Pharmaceuticals pay dividends?
        Actinium Pharmaceuticals does not currently pay dividends.
        What is Actinium Pharmaceuticals’s EPS estimate?
        Actinium Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Actinium Pharmaceuticals have?
        Actinium Pharmaceuticals has 26,997,587 shares outstanding.
          What happened to Actinium Pharmaceuticals’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Actinium Pharmaceuticals?
          Among the largest hedge funds holding Actinium Pharmaceuticals’s share is Royce & Associates LLC. It holds Actinium Pharmaceuticals’s shares valued at 371K.


            Actinium Pharmaceuticals Stock Smart Score

            The Actinium Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
            Learn more about TipRanks Smart Score

            Company Description

            Actinium Pharmaceuticals

            Actinium Pharmaceuticals, Inc. is a clinical-stage, Biopharmaceutical Company focused on developing and potentially commercializing therapies to cell therapies. The firm's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells. Its product pipeline includes Iomab-B, Actimab-A, and Actimab-M. The company was founded in 1993 and is headquartered in New York, NY.


            Top 5 ETFs holding ATNM

            Market Value
            Smart Score
            Vanguard Total Stock Market ETF
            Vanguard Russell 3000 ETF
            Dimensional US Core Equity 1 ETF
            Up to five ETFs with an Outperform Smart Score that hold ATNM. The ETFs are listed according to market value of ATNM within the ETF

            Forecast EPS vs Actual EPS

            Currently, no data available
            Please return soon. This page is being updated.

            Similar Stocks
            Price & Change
            Atossa Therapeutics
            Brainstorm Cell Therapeutics
            Bio-Path Holdings
            Cellectar Biosciences

            Popular Stocks

            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis